Caris Life Sciences, Inc. 4

Brian J. Brille had 13,987 Caris Life Sciences, Inc. common shares withheld to cover taxes on RSU vesting while retaining beneficial ownership of approximately 730,303 shares directly and via a family trust.

On May 15, 2026, Brian J. Brille, Vice Chairman and Executive Vice President of Caris Life Sciences, Inc., had 13,987 shares of common stock withheld at $15.25 per share (approximately $213,829 in value) to cover taxes due upon the vesting and settlement of restricted stock units, a non-open-market, tax-related transaction reported as a disposition. Following this withholding, he beneficially owns 230,303 shares of common stock directly and an additional 500,000 shares indirectly through a family trust, for an estimated aggregate holding value of roughly $11.14 million based on the transaction price, while disclaiming beneficial ownership of the trust shares except to the extent of his pecuniary interest.

Filing Facts

CIK

2019410

Ticker

CAI

Form

4

Source Type

fda

Accession

0002071959-26-000006

Alert Tier

5